{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259159448", "close" : "1259182848", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
ap

SciClone stops trial of pancreatic cancer drug

SciClone Pharma says it stopped study of cancer drug on recommendation from reviewers

  • On 5:47 pm EDT, Friday October 2, 2009

FOSTER CITY, Calif. (AP) -- SciClone Pharmaceuticals Inc. said Friday it has stopped a trial of a late-stage pancreatic cancer drug candidate after analyzing data from the trial.

A data safety monitoring committee recommended the trial of RP101 be stopped, SciClone said. The company will evaluate data from the study.

In aftermarket trading, shares of the biotech drugmaker lost 48 cents, or 11.6 percent, to $3.67. The stock closed at $4.15 in the regular session.

Related Headlines

Related Blog Headlines

Top Stories

Related Message Boards

Sponsored Links

Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.